Webinar: Implementing High-Sensitivity Troponin Testing: Multiple Stakeholders, Multiple Perspectives
Join Clinical Lab Products for this free webcast, sponsored by Beckman Coulter, which provides an overview of high-sensitivity troponin I testing.
Join Clinical Lab Products for this free webcast, sponsored by Beckman Coulter, which provides an overview of high-sensitivity troponin I testing.
Research found that Abbott’s high-sensitivity Troponin I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors.
The test measures blood concentrations of plasma ceramides, a class of lipids that are highly linked to cardiovascular disease processes.
The simple blood test identifies individuals who are at risk of experiencing a heart attack, and for whom early intervention can help.
Read MoreCandidates have demonstrated comparable preclinical efficacy to existing anticoagulants but with substantially lower bleeding liability.
Read MoreCurrent and emerging cardiac markers are signaling improved testing for better patient outcomes.
Read MoreGlobal demand for the company’s heart disease blood test prompts international expansion.
Read MoreThe DiscoveryMap platform from Myriad RBM has identified combinations of 15 protein biomarkers associated with cardiovascular events in patients with diabetes.
Read MoreThe assay delivers cardiac troponin I results in about 15 minutes from either whole blood or plasma samples.
Read MoreThe next-generation sequencing based molecular test detects genomic variations in 213 genes related to familial cardiovascular diseases.
Read MoreDevelopments in lipid testing over recent years may signal a better alternative to taking cholesterol levels when it comes to evaluating patients at risk for cardiovascular events.
Read MoreFinancing from the French public investment bank Bpifrance will fund Magnisense’s MI² project to develop emergency cardiovascular diagnostics using magnetic nanomaterials.
Read MoreThe healthcare system spends significant resources managing the fallout from a cardiac event, but comparatively little is spent to assess risk beforehand.
Read MoreData released at the American College of Cardiology annual scientific sessions suggest that a diagnostic strategy using nuclear magnetic resonance technologies can improve cholesterol management and reduce incidence of cardiovascular events.
Read MoreLaboratory testing plays a vital role in keeping tabs on aging women.
Read MoreThe Presage ST2 immunoassay from Critical Diagnostics can detect the cardiac biomarker ST2 and help differentiate hypertensive heart failure (HHF) patients from those with hypertension (HT) with or without left ventricular hypertrophy (LVH), according to a new study published in the Journal of Human Hypertension.
Read MoreWarfarin, Plavix sensitivity tests, and thrombophilia risk test provide personalized risk assessment, diagnosis, and treatment.
Read MoreThe newly validated tests cover the major causes of cardiomyopathies, arrhythmia disorders, and other genetically transmitted diseases that affect the heart and vasculature.
Read More